The Gabelli Healthcare & Wellness Trust (GRX)
Financial Services · NYQ
Fundamentals
Valuation and ratings
The Gabelli Healthcare & Wellness Trust trades at USD9.56, which is 60% above the USD3.82 our discounted cash flow model puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 5 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 63.7 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
GRX dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2026 (year to date) | USD0.340 | 2 |
| 2025 | USD0.660 | 4 |
| 2024 | USD0.600 | 4 |
| 2023 | USD0.600 | 4 |
| 2022 | USD0.600 | 4 |
| 2021 | USD0.960 | 5 |
| 2020 | USD0.580 | 4 |
| 2019 | USD0.560 | 4 |
| 2018 | USD0.520 | 4 |
| 2017 | USD0.520 | 4 |
| 2016 | USD0.520 | 4 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
About The Gabelli Healthcare & Wellness Trust
The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
GRX passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Common questions
Is The Gabelli Healthcare & Wellness Trust (GRX) undervalued?
Against our discounted cash flow estimate of USD3.82, GRX at USD9.56 is 60% above fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.
What is GRX's P/E ratio?
GRX trades at 63.7 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Does The Gabelli Healthcare & Wellness Trust (GRX) pay a dividend?
Yes. The Gabelli Healthcare & Wellness Trust yields 7.02% at the current share price. It has paid USD0.680 per share over the trailing twelve months. It has paid a dividend in each of the last 14 complete calendar years. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.
The full research page for GRX, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.